If you believe, as I do, that the recent macro weakness is a minor correction, not the harbinger of the end of days (as appeared to be the case Wednesday afternoon), then ZELTIQ Aesthetics (NASDAQ:ZLTQ) is a strong buy. The company's CoolSculpting "body contouring" product is extremely economically insensitive; it's not covered by insurance, and average cost moves well into the four figures.
Indeed, it's likely that macro concerns have led to the stock's recent decline.
(click to enlarge)
Indeed, with the exception of Cynosure (NASDAQ:CYNO), the energy-based aesthetics space has underperformed the market of late, and CYNO is down nearly 15% YTD.
ZLTQ data by YCharts
Admittedly, this has long been a
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|
|PRO Top long ideas returned 21.7% in 2016**|